Healthcare
Sintx Technologies, Inc.(SINT)
Live Price
Offline$2.12
-4.07% today
1Y Change
-28.33%
Window
Jun 20, 2025 โ Jun 3, 2026
- Market Cap
- $10.00M
- Revenue Growth
- -18.3%
- EPS Growth
- +58.6%
- Dividend Yield
- 0.0%
Coverage: 239 bars ยท Jun 20, 2025 โ Jun 3, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sintx Technologies, Inc. (SINT) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $2.12 and down 28.3% across the available one-year price window (Jun 20, 2025 โ Jun 3, 2026). Baseline metrics include revenue growth of -18.3%, EPS growth of +58.6%, a dividend yield of 0.0%. What stands out right now is revenue -18.3%, EPS +58.6%, free cash flow +6.2% with operating margin -1053.1% and ROIC -173.7%. Valuation sits in the middle of the pack at price/sales 6.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SINT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-18.3% vs +7.6% peer median
Operating Margin
Below sector median
-1053.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 15, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -18.3% and EPS is at +58.6%, with operating margin around -1053.1%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 2, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 15, 2026 | โ | -1.5% | +5.5% | โ |
2026 Mar 18, 2026 | -1.8% | -3.0% | -3.8% | +0.8% |
2025 Nov 12, 2025 | -529.1% | -10.8% | -2.0% | +14.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SINT
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SINT Max Drawdown
-63.88%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SINT and SPY.
Company Overview
Sintx Technologies, Inc.
NASDAQ Capital Market
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
- Leadership
- Eric K. Olson
- IPO Date
- Feb 13, 2014
- Employees
- 20
- Street Address
- 1885 West 2100 South
- Mailing
- Salt Lake City, UT, 84119
- Region
- Salt Lake City, UT, US
- Reporting Currency
- USD
- Investor Line
- 801 839 3500
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 6.6
- Price/Book
- 2.3
Growth
- Revenue
- -18.3%
- EPS
- +58.6%
- Free Cash Flow
- +6.2%
Profitability
- Gross Margin
- -19.7%
- Operating Margin
- -1053.1%
- Net Margin
- -1678.1%
- ROE
- -400.1%
- ROIC
- -173.7%
Balance Sheet
- Debt/Equity
- 1.11
- Current Ratio
- 1.51
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.